Published in J Clin Invest on September 01, 1992
Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med (1997) 2.13
Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med (2009) 1.52
Sonic hedgehog expression correlates with fundic gland differentiation in the adult gastrointestinal tract. Gut (2002) 1.46
Topical review. Gastrin and gastric epithelial physiology. J Physiol (1999) 1.28
Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia. Mol Cell Biol (2002) 1.28
Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut (1996) 1.26
Reduced susceptibility of mice overexpressing transforming growth factor alpha to dextran sodium sulphate induced colitis. Gut (1998) 1.21
Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol (1994) 1.13
Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol (1995) 0.95
Successful use of octreotide to treat Ménétrier's disease: a rare cause of abdominal pain, weight loss, edema, and hypoalbuminemia. Dig Dis Sci (2009) 0.93
Immunological and morphogenic basis of gastric mucosa atrophy and metaplasia. Virchows Arch (2004) 0.90
Gastric acid secretion in aquaporin-4 knockout mice. Am J Physiol Gastrointest Liver Physiol (2000) 0.89
Generation of stomach tissue from mouse embryonic stem cells. Nat Cell Biol (2015) 0.86
Acid suppression by proton pump inhibitors enhances aquaporin-4 and KCNQ1 expression in gastric fundic parietal cells in mouse. Dig Dis Sci (2010) 0.86
Mouse models of gastric carcinogenesis. J Gastric Cancer (2014) 0.84
The Association of Ménétrier Disease with Ulcerative Colitis: A Case Report with Implications on the Pathogenesis of Ménétrier Disease. Case Rep Gastroenterol (2010) 0.83
A pediatric non-protein losing Menetrier's disease successfully treated with octreotide long acting release. World J Gastroenterol (2012) 0.82
Histochemical analysis of hyperplastic stomach of TGF-alpha transgenic mice. Dig Dis Sci (1997) 0.79
Inhibition by transforming growth factor (34-43)-alpha, a TGF-alpha antagonist, of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Br J Cancer (1998) 0.78
Integrative roles of transforming growth factor-alpha in the cytoprotection mechanisms of gastric mucosal injury. BMC Gastroenterol (2006) 0.77
Abnormal gastric morphology and function in CCK-B/gastrin receptor-deficient mice. Yale J Biol Med (1999) 0.76
Steroid hormone-dependent overexpression of cytochromes P450 2A in liver tumors of TGF alpha transgenic male mice. J Gastroenterol (1997) 0.76
Ménétrier's Disease: Its Mimickers and Pathogenesis. J Pathol Transl Med (2015) 0.75
Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol (2017) 0.75
Human transforming growth factor-alpha: precursor structure and expression in E. coli. Cell (1984) 5.39
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors. Cancer Res (1987) 4.44
Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell (1990) 4.05
TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell (1990) 3.86
Rat transforming growth factor type 1: structure and relation to epidermal growth factor. Science (1984) 3.62
Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev (1991) 2.78
Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell (1990) 2.63
Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J Biol Chem (1983) 2.42
Expression in rat fibroblasts of a human transforming growth factor-alpha cDNA results in transformation. Cell (1986) 2.41
Trophic action of epidermal growth factor on the pancreas and gastroduodenal mucosa in rats. J Physiol (1982) 1.80
Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal. J Clin Invest (1989) 1.69
The natural history of hypertrophic gastrophy (Menetrier's disease). Report of a case with 16 year follow-up and review of 120 cases from the literature. Am J Med (1977) 1.67
Transformation of normal rat kidney (NRK) cells by an infectious retrovirus carrying a synthetic rat type alpha transforming growth factor gene. Proc Natl Acad Sci U S A (1987) 1.27
Expression and characterization of transforming growth factor alpha precursor protein in transfected mammalian cells. Mol Cell Biol (1987) 1.20
Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas; implication for autocrine growth. Jpn J Cancer Res (1990) 1.18
Transforming growth factor alpha inhibits secretion of gastric acid. Proc Natl Acad Sci U S A (1986) 1.14
Transforming growth factor-alpha: an oncodevelopmental growth factor. Cancer Cells (1990) 1.12
Infection with a TGF-alpha retroviral vector transforms normal mouse mammary epithelial cells but not normal rat fibroblasts. Oncogene (1989) 1.06
A clinicopathologic study of sex cases. Ann Surg (1977) 1.02
Inactivation of a sperm motility gene by insertion of an epidermal growth factor receptor transgene whose product is overexpressed and compartmentalized during spermatogenesis. Genes Dev (1991) 0.92
Epidermal growth factor receptor regulation and function. Semin Cancer Biol (1990) 0.84
Cellular and viral ligands that interact with the EGF receptor. Semin Cancer Biol (1990) 0.83
Transgenic animals in biomedical research. FASEB J (1991) 0.83
Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev (1992) 2.59
Neonatal sunburn and melanoma in mice. Nature (2001) 2.25
Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A (1994) 2.20
Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12
Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res (1993) 2.09
Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07
Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90
Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J (1993) 1.86
Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73
Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67
A freshwater anaerobe coupling acetate oxidation to tetrachloroethylene dehalogenation. Appl Environ Microbiol (1996) 1.66
Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med (1994) 1.66
Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ (1995) 1.62
Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population. Dev Biol (1995) 1.56
DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat Genet (1997) 1.55
Titanium plate fixation: a review of implant failures. J Orthop Trauma (1996) 1.55
c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54
Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J (1992) 1.52
Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48
Effect of leucine metabolite beta-hydroxy-beta-methylbutyrate on muscle metabolism during resistance-exercise training. J Appl Physiol (1985) (1996) 1.42
Variation in human intestinal microbiota with age. Dig Liver Dis (2002) 1.41
Tactile prepuff inhibition of startle in children with Tourette's syndrome: in search of an "fMRI-friendly" startle paradigm. Biol Psychiatry (2001) 1.39
Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology (1992) 1.36
Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36
Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A (1996) 1.27
Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling. FASEB J (2000) 1.26
Analysis of variable (diversity) joining recombination in DNAdependent protein kinase (DNA-PK)-deficient mice reveals DNA-PK-independent pathways for both signal and coding joint formation. Proc Natl Acad Sci U S A (1998) 1.26
Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Joint Surg Br (2012) 1.21
Transforming growth factor alpha disrupts the normal program of cellular differentiation in the gastric mucosa of transgenic mice. Development (1995) 1.14
Overexpression of transforming growth factor-alpha causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol (1994) 1.13
Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation. Oncogene (2010) 1.13
Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest (1999) 1.11
Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1. Cancer Res (1994) 1.11
Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ (1995) 1.10
Development of liver tumors in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.10
In vitro methylation of specific regions of the cloned Moloney sarcoma virus genome inhibits its transforming activity. Mol Cell Biol (1983) 1.08
Molecular and genetic analysis of liver oncogenesis in transforming growth factor alpha transgenic mice. Cancer Res (1992) 1.05
Transduction of host cellular sequences by a retroviral shuttle vector. J Virol (1986) 1.02
The Manchester-Oxford Foot Questionnaire (MOXFQ): Development and validation of a summary index score. Bone Joint Res (2013) 0.99
Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res (2000) 0.99
The MOXFQ patient-reported questionnaire: assessment of data quality, reliability and validity in relation to foot and ankle surgery. Foot (Edinb) (2011) 0.98
Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis. Mol Cell Biol (2000) 0.98
Hepatocyte growth factor/scatter factor-MET signaling in neural crest-derived melanocyte development. Pigment Cell Res (1999) 0.98
Comparison of microbial populations in model and natural rumens using 16S ribosomal RNA-targeted probes. Environ Microbiol (2000) 0.97
Regulation of terminal differentiation of zymogenic cells by transforming growth factor alpha in transgenic mice. Gastroenterology (1995) 0.97
Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett (2001) 0.96
Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects. Am J Hypertens (1994) 0.95
Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol (1995) 0.95
Conservatively treated massive prolapsed discs: a 7-year follow-up. Ann R Coll Surg Engl (2009) 0.95
The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol (2001) 0.93
NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo. Mol Cell Biol (1998) 0.93
Inactivation of a sperm motility gene by insertion of an epidermal growth factor receptor transgene whose product is overexpressed and compartmentalized during spermatogenesis. Genes Dev (1991) 0.92
Determinants of HIV risk among men who have homosexual sex and inject drugs. AIDS Care (1995) 0.92
Renal tubular hyperplasia, polycystic disease, and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest (1997) 0.92
Collaboration between growth factors and diverse chemical carcinogens in hepatocarcinogenesis of transforming growth factor alpha transgenic mice. Cancer Res (1993) 0.91
Cholinergic modification of glucose-induced biphasic insulin release in vitro. J Clin Invest (1974) 0.91
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. Pigment Cell Melanoma Res (2009) 0.89
Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis. Cancer Res (1997) 0.88
Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study. Neurol Res (2005) 0.88
Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord (1995) 0.87
Deep Impact: observations from a worldwide Earth-based campaign. Science (2005) 0.87
Effects of beta-hydroxy-beta-methylbutyrate on muscle damage after a prolonged run. J Appl Physiol (1985) (2000) 0.86
Treatment of spasmodic torticollis with intradural selective rhizotomies. J Neurosurg (1993) 0.86
Increased susceptibility to N-nitrosomethylurea gastric carcinogenesis in transforming growth factor alpha transgenic mice with gastric hyperplasia. Jpn J Cancer Res (1995) 0.86
Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation. Mol Carcinog (1997) 0.86
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens (1995) 0.85
Laboratory studies of the effect of Pall extracorporeal leucocyte filters LG6 and AV6 on patients undergoing coronary bypass grafts. Perfusion (1996) 0.84
Deletion and transposon mutagenesis and sequence analysis of the pRO1600 OriR region found in the broad-host-range plasmids of the pQF series. Plasmid (1994) 0.84
The p53 response to DNA damage in vivo is independent of DNA-dependent protein kinase. Mol Cell Biol (2000) 0.83
Ulcerative proctitis, rectal prolapse, and intestinal pseudo-obstruction in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab Invest (2001) 0.83
Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes (1991) 0.83
Overexpression of a human transforming growth factor-alpha (TGF alpha) transgene reveals a dual antagonistic role of TGF alpha in female sexual development. Endocrinology (1994) 0.82
Genetic dissection of melanoma pathways in the mouse. Semin Cancer Biol (2001) 0.82
Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell Growth Differ (1994) 0.82
Transgenic mouse models of breast cancer. Breast Cancer Res Treat (1996) 0.82
Chitosan inactivates spoilage yeasts but enhances survival of Escherichia coli O157:H7 in apple juice. J Appl Microbiol (2005) 0.81
Halothane binding to a G protein coupled receptor in retinal membranes by photoaffinity labeling. Biochemistry (2000) 0.81
[Sarcoidosis and clear cell carcinoma of the kidney: the sixth case?]. G Chir (2002) 0.81
Incisional hernias: incidence following abdominal aortic aneurysm repair. J Cardiovasc Surg (Torino) (1995) 0.81
Effects of calcium, lanthanum, and bicarbonate ion on epinephrine modification of insulin release in vitro. Diabetes (1979) 0.80
Drugs with anticholinergic properties as a risk factor for psychosis in patients affected by Alzheimer's disease. Clin Pharmacol Ther (2007) 0.80
Immunohistochemical detection of the c-met proto-oncogene product in the congenital melanocytic nevus of an infant with neurocutaneous melanosis. J Am Acad Dermatol (2001) 0.80
Heterotopic pregnancy following administration of human menopausal gonadotropin and following in vitro fertilization and embryo transfer: two case reports and review of the literature. Eur J Obstet Gynecol Reprod Biol (1995) 0.79
Leg muscle pH following sprint running. Med Sci Sports Exerc (1983) 0.79